Lebo Francina Gafane-Matemane

Dr. Lebo Francina Gafane-Matemane

North-West University, Potchefstroom, North West, South Africa
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
ACAshleigh Craig
Ashleigh Craig
RKRuan Kruger
Ruan Kruger
OAOmotayo S. Alaofin
Omotayo S. Alaofin
LWLisa Jayne Ware
Lisa Jayne Ware
AKAndre Pascal Kengne
Andre Pascal Kengne
Recent global and regional reports consistently confirm the high and increasing prevalence of hypertension in sub-Saharan Africa (SSA), with poor detection, treatment, and control rates. This narrative review summarises the burden of hypertension in SSA and recent findings from community-based hypertension management strategies. We further outline prominent risk factors according to recent data and associated underlying mechanisms for hypertension development. An extensive review of literature showed that most countries have reported on the prevalence of hypertension during 2017–2023, despite limitations linked to the lack of nationally representative studies, heterogeneity of sampling and data collection methods. Task-shifting approaches that assign roles to model patients and community health workers reported improved linkage to healthcare services and adherence to medication, with inconsistent findings on blood pressure (BP)-lowering effects over time. The regularly reported risk factors include unhealthy diet, sedentary lifestyle, increased adiposity and underweight, ageing, level of education, and/or income as well as psychosocial factors. Newer data on the pathophysiological mechanisms leading to hypertension and potential areas of intervention are reported from children and adults and include, among others, salt-handling and volume overload, endothelial function, BP dipping patterns and the role of human immunodeficiency virus . To conclude, significant strides have been made in data reporting from SSA on the burden of hypertension in the region as well as biomarker research to improve understanding and identification of areas of intervention. However, gaps remain on linkage between knowledge generation, translation, and implementation research. Coordinated studies addressing both discovery science and public health are crucial to curb hypertension development and improve management in SSA.

6 January 2019 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
Aletta SchutteAletta Schutte
Aletta Schutte
PGPhilimon N Gona
Philimon N Gona
CDChristian Delles
Christian Delles
AUAletta S Uys
Aletta S Uys
ABAdele Burger
Adele Burger
HHHugo W Huisman
Hugo W Huisman
Globally hypertension is stabilising, but in sub-Saharan Africa the incidence of hypertension remains on an increase. Although this might be attributed to poor healthcare and ineffective antihypertensive treatment, there is a limited understanding of population and individual-specific cardiovascular pathophysiology – necessary for effective prevention and treatment strategies in Africa. As there is a lack of longitudinal studies tracking the early pathophysiological development of hypertension in black populations, the African-PREDICT study was initiated. The purpose of this paper is to describe the detailed methodology and baseline cohort profile of the study. From 2013 to 2017, the study included 1202 black (N = 606) and white (N = 596) men and women (aged 20–30 years) from South Africa – screened to be healthy and clinic normotensive. At baseline, and each 5-year follow-up examination, detailed measures of health behaviours, cardiovascular profile and organ damage are taken. Also, comprehensive biological sampling for the ‘omics’ and biomarkers is performed. Overall, the baseline black and white cohort presented with similar ages, clinic and 24-hour blood pressures, but black adults had lower socioeconomic status and higher central systolic blood pressure than white individuals. The prospective African-PREDICT study in young black and white adults will contribute to a clear understanding of early cardiovascular disease development.

23 March 2017 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
Aletta SchutteAletta Schutte
Aletta Schutte
SBS Botha
S Botha
CFC M T Fourie
C M T Fourie
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
Ruan KrugerRuan Kruger
Ruan Kruger
HHH W Huisman
H W Huisman

29 March 2023 in Metabolomics
Verified
Journal Article
Open access
PDF file
WTWessel L du Toit
Wessel L du Toit
Ruan KrugerRuan Kruger
Ruan Kruger
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
Aletta SchutteAletta Schutte
Aletta Schutte
RLRoan Louw
Roan Louw
CMCarina M.C Mels
Carina M.C Mels
Introduction: Increased exposure to risk factors in the young and healthy contributes to arterial changes, which may be accompanied by an altered metabolism. Objectives: To increase our understanding of early metabolic alterations and how they associate with markers of arterial stiffness, we profiled urinary metabolites in young adults with cardiovascular disease (CVD) risk factor(s) and in a control group without CVD risk factors. Methods: We included healthy black and white women and men (N = 1202), aged 20–30 years with a detailed CVD risk factor profile, reflecting obesity, physical inactivity, smoking, excessive alcohol intake, masked hypertension, hyperglycemia, dyslipidemia and low socio-economic status, forming the CVD risk group (N = 1036) and the control group (N = 166). Markers of arterial stiffness, central systolic blood pressure (BP) and pulse wave velocity were measured. A targeted metabolomics approach was followed by measuring amino acids and acylcarnitines using a liquid chromatography-tandem mass spectrometry method. Results: In the CVD risk group, central systolic BP (adjusted for age, sex, ethnicity) was negatively associated with histidine, arginine, asparagine, serine, glutamine, dimethylglycine, threonine, GABA, proline, methionine, pyroglutamic acid, aspartic acid, glutamic acid, branched chain amino acids (BCAAs) and butyrylcarnitine (all P ≤ 0.048). In the same group, pulse wave velocity (adjusted for age, sex, ethnicity, mean arterial pressure) was negatively associated with histidine, lysine, threonine, 2-aminoadipic acid, BCAAs and aromatic amino acids (AAAs) (all P ≤ 0.044). In the control group, central systolic BP was negatively associated with pyroglutamic acid, glutamic acid and dodecanoylcarnitine (all P ≤ 0.033). Conclusion: In a group with increased CVD risk, markers of arterial stiffness were negatively associated with metabolites related to AAA and BCAA as well as energy metabolism and oxidative stress. Our findings may suggest that metabolic adaptations may be at play in response to increased CVD risk to maintain cardiovascular integrity.

22 May 2020 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
Ruan KrugerRuan Kruger
Ruan Kruger
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
JKJuliana Kagura
Juliana Kagura

13 January 2016 in The Journal of Clinical Hypertension
Verified
Journal Article
Closed access
PDF file
LWLisa Jayne Ware
Lisa Jayne Ware
KRKirsten L. Rennie
Kirsten L. Rennie
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
TNTarryn M. Nell
Tarryn M. Nell
JTJane E.S. Thompson
Jane E.S. Thompson
Aletta SchutteAletta Schutte
Aletta Schutte